Improving Preventive Cardiology: The 33rd Bethesda Conference

BETHESDA CONFERENCE REPORT 33rd Bethesda Conference: Preventive Cardiology: How Can We Do Better?*

*The recommendations set forth in this report are those of the conference participants and do not necessarily reflect the official position of the American College of Cardiology Foundation. When citing this document, the American College of Cardiology Foundation would appreciate the following citation format: Preventive cardiology: how can we do better? 582 Fletcher et al.

Task force #3--getting results: who, where, and how? 33rd Bethesda Conference.

the North Karelia Hypertension Program, 1972–1977. Med Care 1986;24:767–80. 60. Littenberg B, Garber AM, Sox HC, Jr. Screening for hypertension. Ann Intern Med 1990;112:192–202. 61. Edelson JT, Weinstein MC, Tosteson AN, Williams L, Lee TH, Goldman L. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA 1990;263:407– 13. 62. Laaser U, Wenzel H. A...

Task force #4--adherence issues and behavior changes: achieving a long-term solution. 33rd Bethesda Conference.

Task force #5--the role of cardiovascular specialists as leaders in prevention: from training to champion. 33rd Bethesda Conference.

Three driving forces call for an intensive effort focused on cardiovascular disease (CVD) prevention: 1) the dominant risk factors for CVD are known; 2) effective interventions are available; 3) CVD remains the leading cause of death. The previous four task forces have outlined the magnitude of the CVD problem, and documented the cost-utility, intervention efficacy, and adherence strategies ava...

BETHESDA CONFERENCE REPORT 28th Bethesda Conference: Practice Guidelines and the Quality of Care*